IMM 0.00% 34.0¢ immutep limited

chemotherapy can boost cancer: study, page-2

  1. 3,639 Posts.
    lightbulb Created with Sketch. 306
    Hi solusnauta. What you have hit upon is "the holy grail" IMO, and it is something I have questioned PRR management about. The following is an email I sent to Dr Frazer in August last year:

    "Hi Neil,

    After doing some research, I have come to realize CVac's potential as a preventative, rather than a theraputic, vaccine.
    Can you answer any of the following questions for me?

    - Have you done any testing pre chemotherapy? No
    - If so, can you tell me what the results were?
    - If not, do you plan on conducting these trials in the future? After we obtain approval, we may broaden out the times of administration in additional clinical studies.
    - What would be the proccess required to gain FDA approval, ie full PH I, II AND III? It's a difficult question. We'd probably need to start with concomitant administration with chemotherapy and work back from there.
    - Will the current Ph III testing only allow you to administer CVac post chemotherapy? For EU, US and Australia-Yes"

    One day...hopefully...surely...common sense will prevail.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.